These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 33901292)
1. Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clirnical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". Lao Q; Merke DP J Clin Endocrinol Metab; 2021 Jun; 106(7):e2835-e2836. PubMed ID: 33901292 [No Abstract] [Full Text] [Related]
2. Response to Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". Marino R; Perez Garrido N; Ramirez P; Belgorosky A J Clin Endocrinol Metab; 2021 Jun; 106(7):e2837-e2838. PubMed ID: 33901286 [No Abstract] [Full Text] [Related]
4. The Prevalence of the Chimeric TNXA/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency. Gao Y; Lu L; Yu B; Mao J; Wang X; Nie M; Wu X J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32291442 [TBL] [Abstract][Full Text] [Related]
5. Chimeric CYP21P/CYP21 and TNXA/TNXB genes in the RCCX module. Lee HH Mol Genet Metab; 2005 Jan; 84(1):4-8. PubMed ID: 15639189 [TBL] [Abstract][Full Text] [Related]
10. Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia. Merke DP; Chen W; Morissette R; Xu Z; Van Ryzin C; Sachdev V; Hannoush H; Shanbhag SM; Acevedo AT; Nishitani M; Arai AE; McDonnell NB J Clin Endocrinol Metab; 2013 Feb; 98(2):E379-87. PubMed ID: 23284009 [TBL] [Abstract][Full Text] [Related]
11. A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia. Lao Q; Mallappa A; Rueda Faucz F; Joyal E; Veeraraghavan P; Chen W; Merke DP Mol Genet Genomic Med; 2021 Feb; 9(2):e1556. PubMed ID: 33332743 [TBL] [Abstract][Full Text] [Related]
12. Salt-wasting congenital adrenal hyperplasia phenotype as a result of the TNXA/TNXB chimera 1 (CAH-X CH-1) and the pathogenic IVS2-13A/C > G in CYP21A2 gene. Fanis P; Skordis N; Phylactou LA; Neocleous V Hormones (Athens); 2023 Mar; 22(1):71-77. PubMed ID: 36264454 [TBL] [Abstract][Full Text] [Related]
14. Erratum to: Letter to the Editor from Lao and Merke: "Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA/TNXB Chimeras in Congenital Adrenal Hyperplasia". J Clin Endocrinol Metab; 2021 Nov; 106(12):e5284. PubMed ID: 34351424 [No Abstract] [Full Text] [Related]
16. Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome. Miller WL; Merke DP Horm Res Paediatr; 2018; 89(5):352-361. PubMed ID: 29734195 [TBL] [Abstract][Full Text] [Related]
17. Congenital adrenal hyperplasia with a Ivo CR; Fitas AL; Madureira I; Diamantino C; Gomes S; Gonçalves J; Lopes L J Pediatr Endocrinol Metab; 2023 Jan; 36(1):81-85. PubMed ID: 36259452 [TBL] [Abstract][Full Text] [Related]
18. High-Throughput Screening for CYP21A1P-TNXA/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia. Lao Q; Brookner B; Merke DP J Mol Diagn; 2019 Sep; 21(5):924-931. PubMed ID: 31229653 [TBL] [Abstract][Full Text] [Related]
19. Evaluating the efficacy of a long-read sequencing-based approach in the clinical diagnosis of neonatal congenital adrenocortical hyperplasia. Zhang R; Cui D; Song C; Ma X; Cai N; Zhang Y; Feng M; Cao Y; Chen L; Qiang R Clin Chim Acta; 2024 Mar; 555():117820. PubMed ID: 38307397 [TBL] [Abstract][Full Text] [Related]
20. PCR-based detection of the CYP21 deletion and TNXA/TNXB hybrid in the RCCX module. Lee HH; Lee YJ; Lin CY Genomics; 2004 May; 83(5):944-50. PubMed ID: 15081125 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]